The potential use of blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.

被引：0
|
作者：
Christensen, Troels Dreier
Jensen, Christina
Willumsen, Nicholas
Larsen, Ole
Leerhoy, Bonna
Hansen, Carsten Palnaes
Madsen, Kasper
Nielsen, Dorte
Johansen, Julia S.
机构：
[1] Copenhagen Univ Hosp, Dept Oncol, Herlev, Denmark
[2] Nordic Biosci, Biomarkers & Res, Herlev, Denmark
[3] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Digest Dis Ctr, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Surg Gastroenterol, Rigshospitalet, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Dept Surg Gastroenterol, Rigshospitalet, Copenhagen, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4082
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer
    Christensen, Troels D.
    Jensen, Christina
    Larsen, Ole
    Leerhoy, Bonna
    Hansen, Carsten P.
    Madsen, Kasper
    Hogdall, Dan
    Karsdal, Morten A.
    Chen, Inna M.
    Nielsen, Dorte
    Johansen, Julia S.
    Willumsen, Nicholas
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (05) : 1036 - 1049
  • [2] Blood-based genomic profiling of circulating tumor DNA from patients with advanced biliary tract cancer.
    Wang, Junying
    Song, Jia
    Zhao, Jing
    Zhang, Yuzi
    Cai, Shangli
    Chen, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer
    Han, Sung Yong
    Park, Sung Hee
    Ko, Hyun Suk
    Jang, Aelee
    Seo, Hyung Il
    Lee, So Jeong
    Kim, Gwang Ha
    Kim, Dong Uk
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [4] Vimentin-positive circulating tumor cells as diagnostic and prognostic biomarkers in biliary tract cancer patients
    Han, S.
    Kim, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S163 - S163
  • [5] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Nissen, N. I.
    Kehlet, S.
    Boisen, M. K.
    Liljefors, M.
    Jensen, C.
    Johansen, A. Z.
    Johansen, J. S.
    Erler, J.
    Karsdal, M. A.
    Mortensen, J.
    Hoye, A.
    Willumsen, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S290 - S290
  • [6] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Nissen, Neel, I
    Kehlet, Stephanie
    Boisen, Mogens K.
    Liljefors, Maria
    Jensen, Christina
    Johansen, Astrid Z.
    Johansen, Julia S.
    Erler, Janine T.
    Karsdal, Morten
    Mortensen, Joachim H.
    Hoye, Anette
    Willumsen, Nicholas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Neel I. Nissen
    Stephanie Kehlet
    Mogens K. Boisen
    Maria Liljefors
    Christina Jensen
    Astrid Z. Johansen
    Julia S. Johansen
    Janine T. Erler
    Morten Karsdal
    Joachim H. Mortensen
    Anette Høye
    Nicholas Willumsen
    Scientific Reports, 11
  • [8] Diagnostic potential of blood-based biomarkers in multiple sclerosis
    Holm Nielsen, Signe
    Karsdal, Morten
    Manoel, Bruna
    Bay-Jensen, Anne-Christine
    Henriksen, Kim
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [9] Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers
    Swellam, Menha
    Ramadan, Amal
    El-Hussieny, Enas A.
    Bakr, Noha M.
    Hassan, Naglaa M.
    Sobeih, Mohamed Emam
    EzzElArab, Lobna R.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (08) : 12321 - 12330
  • [10] Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy
    Schlange, Thomas
    Pantel, Klaus
    PHARMACOGENOMICS, 2016, 17 (03) : 183 - 186
12345